Subscribe to Newsletter
Diagnostics Genetics and epigenetics

Head or Heart

Schizophrenia is mostly associated with psychiatric symptoms, including hallucinations, psychosis, and delusion. But could there be a somatic, less mentally focused component to the disease that we don’t yet fully understand? A recent paper in The American Journal of Psychiatry has established a genetic link between cardiovascular disease (CVD) and schizophrenia (1).

It was previously known that schizophrenia carried an increased risk of CVD in individuals – up to two- to threefold greater in some cases (2) – but the mechanisms behind this link have historically not been well understood. For example, there is a recorded prevalence of lower BMI in those diagnosed with schizophrenia at the moment of diagnosis, yet those with schizophrenia are also more likely to be obese. In a bid to reveal the potential genetic causes for the increased risk, researchers analyzed genome-wide association study (GWAS) results for any genetic architecture shared between schizophrenia and CVD risk factors.

The study found that a significant number of genetic variants that underlie schizophrenia also have an effect on CVD phenotypes.The team stated that they discovered “extensive genetic overlap” between two groups of risk factors. The team also identified certain specific areas in the genetic code that are shared between schizophrenia and CVD related factors, such as BMI, blood pressure, type 2 diabetes, waist-to-hip ratio, heart disease, among others. 

The paper concludes that there is an “inherent propensity” to smoking behaviors in those with schizophrenia. Interestingly, a number of risk loci for schizophrenia are protective against CVD-influencing obesity. More research that leverages even larger GWAS datasets will be needed to explore the genetic reasons behind these comorbidities in greater detail.

Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. L Rødevand et al., “Characterizing the Shared Genetic Underpinnings of Schizophrenia and Cardiovascular Disease Risk Factors,” Am J Psychiatry (2023). PMID: PMID: 37752828.
  2. IH Heiberg et al., “Total and cause-specific standardized mortality ratios in patients with schizophrenia and/or substance use disorder,” PLoS One, 13, (2018). PMID: 30138449.
About the Author
George Francis Lee

Deputy Editor, The Pathologist

Interested in how disease interacts with our world. Writing stories covering subjects like politics, society, and climate change.

Related Application Notes
Evaluation of cell-free fetal DNA to determine fetal RhD status

| Contributed by Revvity

Preventing Bias in scRNAseq Performed on Solid Tumors

| Contributed by Revvity

Enabling Efficient, Cost-effective Sequencing of the Human Whole Exome

| Contributed by Revvity

Related Product Profile
Diagnostics Genetics and epigenetics
QIAseq® Pan Cancer Multimodal cuts user interventions by 50%

| Contributed by QIAGEN

Most Popular
Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register